Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: insights from the EMPA-REG OUTCOME trial - Wanner, Christoph; Inzucchi, Silvio E.; Zinman, Bernard; Koitka-Weber, Audrey; Mattheus, Michaela; George, Jyothis T.; Eynatten, Maximilian von; Hauske, Sibylle J. (Diabetes, obesity and metabolism, 2020)
Gesehen am 20.10.2025